Stay updated on Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial
Sign up to get notified when there's something new on the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page.

Latest updates to the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows Revision: v3.6.5, replacing the previous v3.6.4, signaling a new site release of the ClinicalTrials.gov interface on the study history page.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe site software version was updated from v3.6.3 to v3.6.4, indicating an underlying platform or UI update rather than changes to study content.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe revision label on the page shows v3.6.3, replacing the previous v3.6.2, indicating a maintenance update to the interface for this study history view.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2 on the history page, signaling a newer software release. This is a non-content change reflecting an update to the page's underlying system.SummaryDifference0.1%

- Check57 days agoChange DetectedThe study history now shows 'Check who can join' and 'Find Contact Information' for easier participation and outreach. The revision label updates from v3.5.5 to v3.6.0.SummaryDifference0.6%

- Check64 days agoChange DetectedA new revision entry v3.5.5 was added to the study record history, and the previous revision v3.5.4 was removed, indicating an updated version in the record history.SummaryDifference0.1%

Stay in the know with updates to Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page.